Abstract:Background: To enhance ocular bioavailability, the traditional strategies have focused on prolonging precorneal retention and improving corneal permeability by nano-carriers with positive charge, thiolated polymer, absorption enhancer and so on. Glycylsarcosine (GS) as an active target ligand of the peptide tranpsporter-1 (PepT-1 ), could specific interact with the PcpT-1 on the cornea and guide the nanoparticles to the treating site. Purpose: The objective of the study was to explore the active targeting intercalated nanocomposites based on chitosan-glutathione-glycylsarcosine (CG-GS) and layered double hydroxides (LDH) as novel carriers for the treatment of mid-posterior diseases. Materials and methods: CG-GS-LDH intercalated nanocomposites were prepared by the coprecipitation hydrothermal method. In vivo precorneal retention study, ex vivo fluorescence images, in vivo experiment for distribution and irritation were studied in rabbits. The cytotoxicity and cellular uptake were studied in human corneal epithelial primary cells (HCEpiC). Results: CG-GS-LDH nanocomposites were prepared successfully and characterized by FTIR and XRD. Experiments with rabbits showed longer precorneal retention and higher distribution of fluorescence probe/model drug. In vitro cytological study, CG-GS-LDII nanocomposites exhibited enhanced cellular uptake compared to pure drug solution. Furthermore, the investigation of cellular uptake mechanisms demonstrated that both the active transport by PepT-1 and clathrin-mediated endocytosis were involved in the internalization of CG-GS-LDH intercalated nanocomposites. An ocular irritation study and a cytotoxicity test indicated that these nanocomposites produced no significant irritant effects. Conclusions: The active targeting intercalated nanocomposites could have great potential for topical ocular drug delivery due to the capacity for prolonging the retention on the ocular surface, enhancing the drug permeability through the cornea, and efficiently delivering the drug to the targeted site.

A Novel Technology Using Transscleral Ultrasound to Deliver Protein Loaded Nanoparticles

Nanoparticles in the Ocular Drug Delivery

Silk fibroin nanoparticles for enhanced bio-macromolecule delivery to the retina

Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery

Development of Nanofibrous Ocular Insert for Retinal Delivery of Fluocinolone Acetonide

Silk Fibroin-Based Nanoparticles for Drug Delivery

Preparation and in Vitro Evaluation of Silk Fibroin Microspheres Produced by a Novel Ultra-Fine Particle Processing System

Synthesis and characterization of silk fibroin microparticles for intra-articular drug delivery

Biocompatibility and Safety of Insulin-Loaded Chitosan Nanoparticles/plgapeg-Plga Hydrogel (ICNPH) Delivered by Subconjunctival Injection in Rats

Intrascleral drug delivery to the eye using hollow microneedles

Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery.

Investigation on the Properties of Regenerated Silk Fibroin and Its Nanoparticles for Drug Delivery

In-situ tear fluid dissolving nanofibers enable prolonged viscosity-enhanced dual drug delivery to the eye

Novel Surface-Modified Nanostructured Lipid Carriers with Partially Deacetylated Water-Soluble Chitosan for Efficient Ocular Delivery

Silk fibroin as a vehicle for drug delivery applications

PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers

Swellable Silk Fibroin Microneedles for Transdermal Drug Delivery.

Functional intercalated nanocomposites with chitosan-glutathione-glycylsarcosine and layered double hydroxides for topical ocular drug delivery.

The Potential Use of Novel Chitosan-Coated Deformable Liposomes in an Ocular Drug Delivery System.

OCTN2- and ATB0,+-targeted nanoemulsions for improving ocular drug delivery

Rapidly dissolving bilayer microneedles enabling minimally invasive and efficient protein delivery to the posterior segment of the eye